Top

Acta Diabetologica

Published in:

28-08-2023 | Obesity | Letter to the Editor

Letter to editor: Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus

Authors: Zahira Rushan, Satesh Kumar

Published in: Acta Diabetologica | Issue 11/2023

Excerpt

To the editors-in-chief, …

de Tejada-Romero MJG, Saavedra-Santana P, de la Rosa-Fernández F et al (2022) Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus. Acta Diabetol 59:1201–1208. https://doi.org/10.1007/s00592-022-01923-x

Walsh JS, Vilaca T (2017) Obesity, Type 2 diabetes and bone in adults. Calcif Tissue Int 100:528–535. https://doi.org/10.1007/s00223-016-0229-0CrossRefPubMedPubMedCentral

Tilling LM, Darawil K, Britton M (2006) Falls as a complication of diabetes mellitus in older people. J Diabetes Complications 20(3):158–162. https://doi.org/10.1016/j.jdiacomp.2005.06.004CrossRefPubMed

Hewston P, Deshpande N (2016) Falls and balance impairments in older adults with Type 2 diabetes: thinking beyond diabetic peripheral neuropathy. Can J Diabetes 40(1):6–9. https://doi.org/10.1016/j.jcjd.2015.08.005CrossRefPubMed

Kumar S, Khatri M, Memon RA et al (2022) Effects of testosterone therapy in adult males with hypogonadism and T2DM: a meta-analysis and systematic review. Diab Metab Syndr 16(8):102588. https://doi.org/10.1016/j.dsx.2022.102588CrossRef

Title: Letter to editor: Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus
Authors: Zahira Rushan
Satesh Kumar
Publication date: 28-08-2023
Publisher: Springer Milan
Keywords: Obesity
Obesity
Diabetes
Type 2 Diabetes
Published in: Acta Diabetologica / Issue 11/2023
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-023-02156-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2023

Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus

Pregestational exposure to hormonal combined contraceptives and risk of gestational diabetes: an observational retrospective population study

Age at type 2 diabetes diagnosis among adults in Germany in 2014, 2019 and 2020

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy

The CEBPA-FGF21 regulatory network may participate in the T2DM-induced skeletal muscle atrophy by regulating the autophagy-lysosomal pathway

Correction to: Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials